Tag Archives: pipeline

Merck analysts to CEO: What’s so great about your pipeline beyond Keytruda?

Sales of Merck & Co.’s immuno-oncology heavy hitter Keytruda soared 66% in the fourth quarter to $ 2.15 billion, surpassing Wall Street’s expectations yet again. But Merck can’t rely solely on one blockbuster’s dutiful performance to drive sales and earnings growth going forward. Analysts’ worries about that fact only intensified on Friday after Merck put… Read More »